We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$758M
AUM Growth
+$10.8M
Cap. Flow
-$14.1M
Cap. Flow %
-1.86%
Top 10 Hldgs %
25.76%
Holding
210
New
11
Increased
76
Reduced
102
Closed
7

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$5.96M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$2.44M
3
XOM icon
ExxonMobil
XOM
+$2.29M
4
ABBV icon
AbbVie
ABBV
+$2.07M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 22.8%
2 Energy 11.9%
3 Industrials 11.23%
4 Consumer Staples 10.78%
5 Technology 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSM icon
201
MSC Industrial Direct
MSM
$6.78B
$201K 0.03%
+2,100
New +$191K
PBCT
202
DELISTED
People's United Financial Inc
PBCT
$199K 0.03%
13,131
CFR icon
203
Cullen/Frost Bankers
CFR
$10.3B
-2,700
Closed -$209K
LLY icon
204
Eli Lilly
LLY
$1.02T
-4,527
Closed -$266K
OGS icon
205
ONE Gas
OGS
$4.88B
-11,000
Closed -$395K
VB icon
206
Vanguard Morningstar Small-Cap ETF
VB
$79.9B
-1,925
Closed -$217K
VTI icon
207
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
-14,194
Closed -$1.38M
WU icon
208
Western Union
WU
$2.18B
-16,015
Closed -$262K
CTXS
209
DELISTED
Citrix Systems Inc
CTXS
-4,521
Closed -$207K

Similar funds

Boston Financial Management's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Financial Management held 210 positions worth $758M, up 1.5% from $747M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Boston Financial Management's Q2 2014 filing shows 11 new, 76 increased, 102 reduced and 7 closed positions. Its largest new stake was Theravance Biopharma: 16,982 shares worth $541K. The largest sale was IBM, an estimated $5.96M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Energy and Industrials.

  • Boston Financial Management's largest Q2 2014 buy was Theravance Biopharma: 16,982 shares worth $541K.
  • Boston Financial Management added most to Berkshire Hathaway Class B in Q2 2014, an estimated $1.43M increase.
  • Boston Financial Management's biggest Q2 2014 reduction was IBM, cutting an estimated $5.96M.
  • Boston Financial Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2014, selling an estimated $1.38M.
  • Boston Financial Management's ten largest holdings make up 26% of its $758M portfolio in Q2 2014.
  • Boston Financial Management opened 11 new positions and closed 7 in Q2 2014.
  • Boston Financial Management's portfolio value rose 1.5% quarter-over-quarter to $758M.

Based on Boston Financial Management's 13F filing for Q2 2014, filed 20 Aug 2014.